Mycobacterium tuberculosis and TLR2 agonists inhibit induction of type I IFN by TLR7/9

被引：0
|
作者：
Liu, Yi [1 ]
Simmons, Daimon [1 ]
Li, Xiaoxia [3 ]
Abbott, Derek [1 ]
Boom, W. [1 ,2 ]
Harding, Clifford [1 ,2 ]
机构：
[1] Case Western Reserve Univ, Cleveland, OH 44106 USA
[2] Univ Hosp Case Med Ctr, Cleveland, OH USA
[3] Cleveland Clin Fdn, Cleveland, OH 44195 USA
来源：
JOURNAL OF IMMUNOLOGY | 2011年 / 186卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
116.20
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Mycobacterium tuberculosis and TLR2 agonists inhibit induction of type I IFN and MHC-I antigen cross processing by TLR9
    Simmons, Daimon
    Canaday, David
    Liu, Yi
    Boom, W. Henry
    Harding, Clifford
    JOURNAL OF IMMUNOLOGY, 2010, 184
  • [2] Mycobacterium tuberculosis and TLR2 Agonists Inhibit Induction of Type I IFN and Class I MHC Antigen Cross Processing by TLR9
    Simmons, Daimon P.
    Canaday, David H.
    Liu, Yi
    Li, Qing
    Huang, Alex
    Boom, W. Henry
    Harding, Clifford V.
    JOURNAL OF IMMUNOLOGY, 2010, 185 (04): : 2405 - 2415
  • [3] TLR2 Signaling Depletes IRAK1 and Inhibits Induction of Type I IFN by TLR7/9
    Liu, Yi C.
    Simmons, Daimon P.
    Li, Xiaoxia
    Abbott, Derek W.
    Boom, W. Henry
    Harding, Clifford V.
    JOURNAL OF IMMUNOLOGY, 2012, 188 (03): : 1019 - 1026
  • [4] Differential IFN signature for TLR7 and 9 agonists
    Puig, Montse
    Tosh, Kevin
    Grajkowska, Lucia
    Verthelyi, Daniela
    JOURNAL OF IMMUNOLOGY, 2010, 184
  • [5] TLR9 and TLR7 agonists mediate distinct type I IFN responses in humans and nonhuman primates in vitro and in vivo
    Puig, Montserrat
    Tosh, Kevin W.
    Schramm, Lynnsie M.
    Grajkowska, Lucja T.
    Kirschman, Kevin D.
    Tami, Cecilia
    Beren, Joel
    Rabin, Ronald L.
    Verthelyi, Daniela
    JOURNAL OF LEUKOCYTE BIOLOGY, 2012, 91 (01) : 147 - 158
  • [6] Dual TLR2 and TLR7 agonists as HIV latency-reversing agents
    Macedo, Amanda B.
    Novis, Camille L.
    De Assis, Caroline M.
    Sorensen, Eric S.
    Moszczynski, Paula
    Huang, Szu-han
    Ren, Yanqin
    Spivak, Adam M.
    Jones, R. Brad
    Planelles, Vicente
    Basque, Alberto
    JCI INSIGHT, 2018, 3 (19):
  • [7] TRAM Is Required for TLR2 Endosomal Signaling to Type I IFN Induction
    Stack, Julianne
    Doyle, Sarah L.
    Connolly, Dympna J.
    Reinert, Line S.
    O'Keeffe, Kate M.
    McLoughlin, Rachel M.
    Paludan, Soren R.
    Bowie, Andrew G.
    JOURNAL OF IMMUNOLOGY, 2014, 193 (12): : 6090 - 6102
  • [8] TLR2 Promotes Th2/Th17 Responses via TLR4 and TLR7/8 by Abrogating the Type I IFN Amplification Loop
    Wenink, Mark H.
    Santegoets, Kim C. M.
    Broen, Jacobus C. A.
    van Bon, Lenny
    Abdollahi-Roodsaz, Shahla
    Popa, Calin
    Huijbens, Richard
    Remijn, Thijs
    Lubberts, Erik
    van Riel, Piet L. C. M.
    van den Berg, Wim B.
    Radstake, Timothy R. D. J.
    JOURNAL OF IMMUNOLOGY, 2009, 183 (11): : 6960 - 6970
  • [9] TLR9 and TLR7 mediate distinct type I IFN responses in humans and non-human primates
    Puig, Montserrat
    Tosh, Kevin W.
    Schramm, Lynnsie M.
    Grajkowska, Lucja T.
    Kirschman, Kevin D.
    Tami, Cecilia
    Beren, Joel
    Rabin, Ronald L.
    Verthelyi, Daniela
    CYTOKINE, 2011, 56 (01) : 9 - 9
  • [10] TLR7 and TLR9 agonists as efficient adjuvants in Salmonella vaccine formulations
    Yagci, Fuat Cem Cem
    Almacioglu, Kubra
    Gursel, Ihsan
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2021, 51 : 416 - 416
12345